Similarly, the ARF1/ERK pathway has been identified as a key regulator for cancer development in other tumor types.31 However, while these studies have explored the role of ARF1 and ERK signaling in other cancers, the involvement of TMED2 in modulating this pathway in OSCC has been scarcely investigated. This evidence concerns the gene TMED2 and neoplasm.